BIOS Option Care Health Inc

Option Care Health Announces Pricing of Offering of 18,000,000 Shares of Common Stock

Option Care Health Announces Pricing of Offering of 18,000,000 Shares of Common Stock

BANNOCKBURN, Ill., July 21, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today the pricing of an underwritten offering of 18,000,000 shares of its common stock, which includes 10,000,000 shares offered by the Company and 8,000,000 shares offered by an affiliate of Madison Dearborn Partners (the “Selling Stockholder”), at a price to the public of $12.50 per share. The Selling Stockholder has granted the underwriters a 30-day option to purchase up to 2,700,000 additional shares of common stock. The offering is expected to close on July 24, 2020, subject to customary closing conditions.

The Company intends to use the net proceeds received by the Company from the sale of shares of common stock in the offering to repay a portion of its senior secured second lien PIK toggle floating rate notes due 2027. The Selling Stockholder will receive all of the net proceeds from the sale of shares of common stock sold by it in the offering.

BofA Securities is acting as lead bookrunner with Barclays, Deutsche Bank Securities, Goldman Sachs & Co. LLC, J.P. Morgan, Morgan Stanley, SunTrust Robinson Humphrey, William Blair and Lake Street Capital Markets acting as bookrunners for the offering.

A shelf registration statement on Form S-3 relating to the shares of common stock was filed with, and declared effective by, the Securities and Exchange Commission (the “SEC”). The offering may be made only by means of a prospectus supplement and the accompanying prospectus. A preliminary prospectus supplement and accompanying prospectus have been, and a final prospectus supplement will be, filed with the SEC. You may get these documents for free by visiting the SEC’s website at Alternatively, copies may be obtained from:

BofA Securities, Inc.

Attn: Prospectus Department

200 North College Street, 3rd Floor

Charlotte, North Carolina 28255

email:

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor may there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 5,000 teammates, including approximately 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and employees.

Forward-Looking Statements - Safe Harbor

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include statements about the Company’s ability to consummate the offering and the Company’s use of proceeds from the offering.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. For a detailed discussion of the factors that could affect our actual results and financial condition, please refer to the risk factors identified in our SEC reports, including, but not limited to, our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

For Investor Inquiries:

Mike Shapiro, Chief Financial Officer

Option Care Health

312.940.2538

EN
22/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Option Care Health Inc

 PRESS RELEASE

Option Care Health Announces Financial Results for The Second Quarter ...

Option Care Health Announces Financial Results for The Second Quarter Ended June 30, 2024 BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results and Highlights Net revenue of $1,227.2 million, up 14.8% compared to $1,069.1 million in the second quarter of 2023Gross profit of $249.4 million, or 20.3% of ne...

 PRESS RELEASE

Option Care Health to Announce Second Quarter 2024 Financial Results a...

Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details ...

 PRESS RELEASE

Option Care Health to Participate in Upcoming Investor Conferences

Option Care Health to Participate in Upcoming Investor Conferences BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The William Blair 44th Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 4, 2024, including a presentation at 12:00pm CT.The Jefferies Global Healthcare Conference, being held in New York, on Wednesday, June 5, 2024, including a...

 PRESS RELEASE

Option Care Health to Participate in the BofA Securities Health Care C...

Option Care Health to Participate in the BofA Securities Health Care Conference BANNOCKBURN, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the BofA Securities Health Care Conference, being held in Las Vegas, on Tuesday, May 14, 2024, including a fireside chat presentation at 2:20pm PT. The webcast will be available online at . About Option Care Health Option Care Health is the nation’s largest independent provider...

 PRESS RELEASE

Option Care Health Announces Financial Results for the First Quarter E...

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024 BANNOCKBURN, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results and Highlights Net revenue of $1,146.1 million, up 12.8% compared to $1,015.8 million in the first quarter of 2023Gross profit of $238.5 million, or 20.8% of net rev...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch